M. Begoña Ruiz-Argüello

Grifols (Spain) — Spain

Immunology and Microbiology · Life Sciences

20h-index1.6kcitations32works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Biosimilars and Bioanalytical Methods(11), Lipid Membrane Structure and Behavior(10), Pharmaceutical studies and practices(8), Immunodeficiency and Autoimmune Disorders(6), Sphingolipid Metabolism and Signaling(5)

Publications32 total

AB0370 COMPARISON OF A NEW RANDOM-ACCESS SOLUTION FOR THERAPEUTIC DRUG MONITORING OF ADALIMUMAB TO THE REFERENCE ELISA TEST
Annals of the Rheumatic Diseases·2022Open Access
AB0356 THERAPEUTIC DRUG MONITORING: STANDARDIZATION OF PROMONITOR QUICK IFX AND PROMONITOR QUICK ADL POINT OF CARE TESTS WITH WHO INTERNATIONAL STANDARDS FOR THE QUANTIFICATION OF INFLIXIMAB AND ADALIMUMAB IN WHOLE BLOOD AND SERUM
Annals of the Rheumatic Diseases·2022Open Access
AB0369 CORRELATION OF THE FIRST LATERAL FLOW-BASED POINT OF CARE TEST TO QUANTIFY INFLIXIMAB AND ANTI-INFLIXIMAB ANTIBODIES IN A FINGER PRICK SAMPLE WITH THE REFERENCE ELISA TECHNIQUE
Annals of the Rheumatic Diseases·2022· 1 citedOpen Access
AB0354 THERAPEUTIC DRUG MONITORING: PERFORMANCE OF THE FIRST LATERAL FLOW-BASED POINT OF CARE TEST FOR THE QUANTIFICATION OF INFLIXIMAB IN A FINGER PRICK
Annals of the Rheumatic Diseases·2022Open Access
P337 Therapeutic drug monitoring: standardization of Promonitor Quick IFX and Promonitor Quick ADL point of care tests with WHO International Standards for the quantification of infliximab and adalimumab in whole blood and serum
Journal of Crohn s and Colitis·2022Open Access
P342 Correlation of the first lateral flow-based Point of Care test to quantify infliximab and anti-infliximab antibodies in a finger prick sample with the reference ELISA technique
Journal of Crohn s and Colitis·2021· 1 cited
P384 Therapeutic drug monitoring: performance of the first lateral flow-based Point of Care test for the quantification of infliximab in a finger prick
Journal of Crohn s and Colitis·2021· 1 citedOpen Access
AB0405 ADALIMUMAB THERAPEUTIC DRUG MONITORING TEST VALIDATED FOR MEASURING ABP 501 BIOSIMILAR
Annals of the Rheumatic Diseases·2019· 4 citedOpen Access
AB0404 VALIDATION OF A THERAPEUTIC DRUG MONITORING TEST TO MEASURE THE ADALIMUMAB BIOSIMILAR SB5 IN COMPARISON WITH THE REFERENCE ADALIMUMAB
Annals of the Rheumatic Diseases·2019· 2 citedOpen Access
P431 Validation of a therapeutic drug monitoring test to measure the adalimumab biosimilar SB5 in comparison with the reference adalimumab
Journal of Crohn s and Colitis·2019Open Access
P329 Adalimumab therapeutic drug monitoring test validated for measuring ABP 501 biosimilar
Journal of Crohn s and Colitis·2019· 1 citedOpen Access
Chemokines cooperate with TNF to provide protective anti-viral immunity and to enhance inflammation
Nature Communications·2018· 36 citedOpen Access
Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease
Inflammatory Bowel Diseases·2018· 53 citedOpen Access
Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars
Annals of the Rheumatic Diseases·2016· 76 cited
A New Biomarker Panel in Bronchoalveolar Lavage for an Improved Lung Cancer Diagnosis
Journal of Thoracic Oncology·2014· 44 cited
An Ectromelia Virus Protein That Interacts with Chemokines through Their Glycosaminoglycan Binding Domain
Journal of Virology·2007· 56 citedOpen Access
A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus
Proceedings of the National Academy of Sciences·2006· 137 citedOpen Access
Both soluble and membrane-anchored forms of Felid herpesvirus 1 glycoprotein G function as a broad-spectrum chemokine-binding protein
Journal of General Virology·2005· 30 cited
Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanism
Journal of General Virology·2004· 36 cited
Lipid Phase Coexistence Favors Membrane Insertion of Equinatoxin-II, a Pore-forming Toxin from Actinia equina
Journal of Biological Chemistry·2004· 136 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Daniel Nagore(13), Félix M. Goñi(9), Alicia Alonso(9), A Maguregui(8), Antonio Pérez‐Martínez(6), J Pascual(6), L. Del Rio(6), Amagoia Ametzazurra(6), Antonio Alcamı́(4), A. Urigoitia(4), Blanca García‐Barreno(3), J.J. Skehel(3), José A. Melero(3), Gorka Basáñez(3), Luis González-Reyes(2), Alı́ Alejo(2), Vincent P. Smith(2), Margarida Saraiva(2), Ainhoa Ruiz del Agua(2), Diana Martı́n(2)